AGXT p.Pro11His
c.32C>A · rs34116584 · VCV204018
Computational evidence
| Protein change | ||
| AlphaMissense | 0.4996 | ambiguous |
|---|---|---|
| REVEL | 0.557 | indeterminate |
| SaProt | LLR -12.65 | damaging |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.3 | GERP 1.3, phastCons 1 |
| Regional constraint | o/e 1.00 | unconstrained · MANE · 9,952 bp · p 0.92 · regional, not allelic |
| Overall | ||
| CADD | 23.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.0736% | 1,359 |
| European (non-Finnish) | 0.0687% | 1,455 |
| Remaining individualsnot grpmax-eligible | 0.056% | 1,785 |
| Admixed American | 0.0317% | 3,157 |
| South Asian | 0.0242% | 4,138 |
| African / African-American | 0.024% | 4,170 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- AGXT
- Protein
- p.Pro11His
- Coding
- c.32C>A
- MANE Select
- NM_000030
- dbSNP
- rs34116584
- Type
- single nucleotide variant
- Location
- chr2:240868897 (GRCh38)
- Gene constraint
- LOEUF 1.251 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 98.30 · 17 PDB
- Residue 11
- an α-helix; a UniProt-annotated variant site (in allele minor; associated in cis with m-340; decreased specific alanine--glyoxylate aminotransferase activity in vitro when associated with m-340; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with i-152 and m-340; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with r-170 and m-340; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with t-244 and m-340; causes mitochondrial mistargeting when associated with r-170 and m-340)
Disease context
primary hyperoxaluria type 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: alanine glyoxylate aminotransferase deficiency
For Primary hyperoxaluria (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- All ages
- Prevalence
- 1-9 / 1 000 000 (Germany)
Similar variants
- AGXT p.Pro11Ala Uncertain significance ★★ ⚠ same residue
- AGXT p.Pro11Ser Uncertain significance ★★ ⚠ same residue
- AGXT p.Pro11Arg Conflicting classifications of pathogenicity ★ ⚠ same residue
- AGXT p.Pro11fs Likely pathogenic ★ same residue
- AGXT p.Pro11= Likely benign ★ same residue
- AGXT c.358+1G>A Pathogenic ★★ same condition
- AGXT c.359-2A>G Likely pathogenic ★★ same condition
- AGXT c.423+1G>A Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/agxt-p-pro11his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown